Literature DB >> 10836273

Effect of vaccination with Brucella abortus strain RB51 on heifers and pregnant cattle.

F A Uza1, L Samartino, G Schurig, A Carrasco, K Nielsen, R F Cabrera, H R Taddeo.   

Abstract

Thirteen cows, which had been vaccinated as calves with strain 19, were revaccinated twice or three times as adults with I x 109 cfu of B. abortus strain RB51. Their serological responses following adult vaccination remained negative to conventional brucellosis surveillance tests. Vaccination with strain RB51 during the eighth month of pregnancy did not induce abortion, although strain RB51 was recovered from milk for up to 69 days after vaccination. In a parallel study, thirteen 8- to 10-month-old heifers were vaccinated as calves with 109 cfu of strain RB51. The heifers remained seronegative to conventional brucellosis surveillance tests but antibody responses to RB51 could be demonstrated using an indirect ELISA. This study showed that multiple vaccination with strain RB51 did not induce seroconversion to brucellosis surveillance tests. In addition, this study suggests that 109 cfu of strain RB51 is safe for use in pregnant cattle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10836273     DOI: 10.1023/a:1006468713614

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  17 in total

1.  Evaluation of a competitive ELISA for the diagnosis of bovine brucellosis.

Authors:  F A Uzal; A E Carrasco; K H Nielsen
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

2.  Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51.

Authors:  M G Stevens; S C Olsen; M V Palmer; G W Pugh
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  The production and evaluation of a buffered plate antigen for use in a presumptive test for brucellosis.

Authors:  R D Angus; C E Barton
Journal:  Dev Biol Stand       Date:  1984

4.  Human exposure to Brucella abortus strain RB51--Kansas, 1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1998-03-13       Impact factor: 17.586

5.  An indirect ELISA using a monoclonal anti IgG1 enzyme conjugate for the diagnosis of bovine brucellosis.

Authors:  F A Uzal; A E Carrasco; K Nielsen; S Echaide; R F Cabrera
Journal:  Vet Microbiol       Date:  1996-09       Impact factor: 3.293

6.  Biological properties of RB51; a stable rough strain of Brucella abortus.

Authors:  G G Schurig; R M Roop; T Bagchi; S Boyle; D Buhrman; N Sriranganathan
Journal:  Vet Microbiol       Date:  1991-07       Impact factor: 3.293

7.  Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51.

Authors:  P H Elzer; F M Enright; L Colby; S D Hagius; J V Walker; M B Fatemi; J D Kopec; V C Beal; G G Schurig
Journal:  Am J Vet Res       Date:  1998-12       Impact factor: 1.156

8.  Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus.

Authors:  N F Cheville; M G Stevens; A E Jensen; F M Tatum; S M Halling
Journal:  Am J Vet Res       Date:  1993-10       Impact factor: 1.156

9.  Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51.

Authors:  M G Stevens; S G Hennager; S C Olsen; N F Cheville
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

10.  Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.

Authors:  M P Jiménez de Bagüés; P H Elzer; S M Jones; J M Blasco; F M Enright; G G Schurig; A J Winter
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more
  8 in total

1.  Safety of vaccination against brucellosis with the rough strain in pregnant cattle.

Authors:  Adriana Agostini Barbosa; Ana Cristina Silva Figueiredo; Miller Pereira Palhao; Joao Henrique Moreira Viana; Carlos Antonio Carvalho Fernandes
Journal:  Trop Anim Health Prod       Date:  2017-08-15       Impact factor: 1.559

2.  Serological and bacteriological responses of water buffalo (Bubalus bubalis) vaccinated with two doses of Brucella abortus strain RB51 vaccine.

Authors:  Anil Ramnanan; Michael Diptee; Zinora Asgarali; Mervyn Campbell; Abiodun Adewale Adesiyun
Journal:  Trop Anim Health Prod       Date:  2012-10       Impact factor: 1.559

3.  Isolation of Brucella melitensis from a RB51-vaccinated seronegative goat.

Authors:  Enrique Herrera; Aldo Rivera; E Gabriela Palomares; Rigoberto Hernández-Castro; Efrén Díaz-Aparicio
Journal:  Trop Anim Health Prod       Date:  2011-04-01       Impact factor: 1.559

4.  Facing the Human and Animal Brucellosis Conundrums: The Forgotten Lessons.

Authors:  Edgardo Moreno; José-María Blasco; Ignacio Moriyón
Journal:  Microorganisms       Date:  2022-04-30

5.  Isolation of a field strain of Brucella abortus from RB51-vaccinated- and brucellosis-seronegative bovine yearlings that calved normally.

Authors:  Beatriz Arellano-Reynoso; Francisco Suárez-Güemes; Félix Mejía Estrada; Fernando Michel-GómezFlores; Rigoberto Hernández-Castro; Rómulo Beltrán Acosta; Efrén Díaz-Aparicio
Journal:  Trop Anim Health Prod       Date:  2012-09-07       Impact factor: 1.559

Review 6.  Brucellosis in Colombia: Current Status and Challenges in the Control of an Endemic Disease.

Authors:  Lisa M Avila-Granados; Daniel G Garcia-Gonzalez; Jorge L Zambrano-Varon; Angela M Arenas-Gamboa
Journal:  Front Vet Sci       Date:  2019-09-24

7.  Detection of Brucella abortus Vaccine Strain RB51 in Water Buffalo (Bubalus bubalis) Milk.

Authors:  Daniela Averaimo; Fabrizio De Massis; Giovanni Savini; Giuliano Garofolo; Flavio Sacchini; Anna Abass; Manuela Tittarelli; Giacomo Migliorati; Antonio Petrini
Journal:  Pathogens       Date:  2022-06-30

Review 8.  A history of the development of Brucella vaccines.

Authors:  Eric Daniel Avila-Calderón; Ahidé Lopez-Merino; Nammalwar Sriranganathan; Stephen M Boyle; Araceli Contreras-Rodríguez
Journal:  Biomed Res Int       Date:  2013-06-03       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.